The index event cost per patient and per patient-month was higher for new ACS patients.

The new ACS guidelines are the result of a review of new evidence on the benefits and harms of breast cancer screening.

The new ACS cohort was more likely to have myocardial infarction and be hospitalised for the index event, leading to higher index event costs.